Tailee Tucker

Tailee Tucker supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in procuring critical scientific and operational capabilities that advance public health preparedness and response. She manages a diverse portfolio of acquisitions focused on laboratory diagnostics, biomedical research, and data-driven surveillance systems, ensuring the CDC can rapidly deploy tools to detect, analyze, and mitigate infectious disease threats. Her work directly enables the agency’s mission by securing high-integrity scientific services and specialized equipment essential for national health security, with a strong emphasis on technical rigor and compliance with federal procurement regulations. Tucker maintains strategic relationships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid, partnering with organizations that deliver advanced diagnostic platforms, infectious disease research services, and large-scale public health infrastructure support. Her contracting approach emphasizes performance-based outcomes and technical excellence, often engaging vendors with proven expertise in biosafety-level laboratories, genomic sequencing, and epidemiological data systems. These partnerships are characterized by long-term collaboration and a shared commitment to innovation in public health science. Tucker’s procurement activity reflects a strong preference for full and open competition, with 100% of awards issued without set-asides for 8(a), HUBZone, or SDVOSB programs. While small business participation is not formally prioritized in her portfolio, she ensures compliance with all federal socioeconomic requirements and evaluates vendor capabilities based on technical merit and mission alignment rather than socioeconomic designation. Her primary NAICS focus areas include research and development in life sciences (541715), hazardous waste treatment and disposal (562211), and specialized professional services (541990), reflecting her expertise in procuring high-complexity scientific support, biohazard management, and analytical services. She routinely sources next-generation diagnostic technologies, laboratory automation systems, and data analytics platforms critical to CDC’s response infrastructure.